分类：
肝硬化
8-13-2024
New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis
干细胞
,
肝硬化
8-13-2024
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
干细胞
,
肝硬化
8-13-2024
Stem Cells From Human Exfoliated Deciduous Teeth Alleviate Liver Cirrhosis via Inhibition of Gasdermin D-Executed Hepatocyte Pyroptosis
干细胞
,
肝硬化
8-13-2024
Synergistic Hepatoprotective Effects of Mesenchymal Stem Cellsand Platelet-Rich Plasma in a Rat Model of Bile DuctLigation-Induced Liver Cirrhosis
干细胞
,
肝硬化
8-13-2024
Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis
干细胞
,
肝硬化
8-13-2024
Therapeutic effect of autologous bone marrow cells injectedinto the liver under the guidance of B‑ultrasound in thetreatment of HBV‑related decompensated liver cirrhosis
干细胞
,
肝硬化
8-13-2024
Transplantation of Autologous Mesenchymal Stem Cells forEnd-Stage Liver Cirrhosis: A Meta-Analysis Based on SevenControlled Trials
干细胞
,
肝硬化
8-13-2024
New advances of NG2-expressing cell subset in marrow mesenchymal stem cells as novel therapeutic tools for liver fibrosis/cirrhosis
干细胞
,
肝硬化
8-13-2024
Human umbilical cord mesenchymal stem cells improveliver function and ascites in decompensated livercirrhosis patients
干细胞
,
肝硬化
8-13-2024
Human Mesenchymal Stem Cell Transfusion Is Safeand Improves Liver Function in Acute-on-ChronicLiver Failure Patients
干细胞
,
肝硬化
下一页
→